##gff-version 3
##sequence-region Q9NSU2 1 314
Q9NSU2	UniProtKB	Chain	1	314	.	.	.	ID=PRO_0000109868;Note=Three-prime repair exonuclease 1	
Q9NSU2	UniProtKB	Region	20	21	.	.	.	Note=Substrate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Region	54	63	.	.	.	Note=Proline-rich region;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Region	236	314	.	.	.	Note=Necessary for endoplasmic reticulum localization;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Region	243	314	.	.	.	Note=Interaction with UBQLN1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Region	281	314	.	.	.	Note=Necessary for cytoplasmic retention;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Active site	195	195	.	.	.	Note=Proton donor/acceptor;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Metal binding	18	18	.	.	.	Note=Magnesium 1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Metal binding	18	18	.	.	.	Note=Magnesium 2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Metal binding	20	20	.	.	.	Note=Magnesium 1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Metal binding	200	200	.	.	.	Note=Magnesium 1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Binding site	129	129	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Binding site	200	200	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NSU2	UniProtKB	Modified residue	78	78	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9NSU2	UniProtKB	Modified residue	167	167	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9NSU2	UniProtKB	Modified residue	261	261	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q9NSU2	UniProtKB	Alternative sequence	1	10	.	.	.	ID=VSP_010445;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:10393201;Dbxref=PMID:10393201	
Q9NSU2	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_059279;Note=In isoform 1. M->MGPGARRQGRIVQGRPEMCFCPPPTPLPPLRILTLGTHTPTPCSSPGSAAGTYPTM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:11278605;Dbxref=PMID:11278605	
Q9NSU2	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_037948;Note=In CHBL1 and AGS1%3B loss of function. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17440703,ECO:0000269|PubMed:20799324;Dbxref=dbSNP:rs121908117,PMID:17440703,PMID:20799324	
Q9NSU2	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_028319;Note=In AGS1 and SLE%3B primary fibroblasts from an AGS1 patient carrying H-169 show defective G1/S transition and chronic G2/M DNA damage checkpoint activation%3B strongly reduces activity. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16845398,ECO:0000269|PubMed:17293595,ECO:0000269|PubMed:17660818,ECO:0000269|PubMed:17846997,ECO:0000269|PubMed:18045533,ECO:0000269|PubMed:20131292;Dbxref=dbSNP:rs72556554,PMID:16845398,PMID:17293595,PMID:17660818,PMID:17846997,PMID:18045533,PMID:20131292	
Q9NSU2	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_070899;Note=In AGS1%3B increases ubiquitination levels%3B no effect on exonuclease activity. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17846997,ECO:0000269|PubMed:23979357;Dbxref=dbSNP:rs79993407,PMID:17846997,PMID:23979357	
Q9NSU2	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_037949;Note=In SLE. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17660818;Dbxref=dbSNP:rs762011967,PMID:17660818	
Q9NSU2	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_070900;Note=In AGS1%3B increases ubiquitination levels%3B no effect on exonuclease activity. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20131292,ECO:0000269|PubMed:23979357;Dbxref=dbSNP:rs1416519719,PMID:20131292,PMID:23979357	
Q9NSU2	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_028320;Note=In AGS1%3B heterozygous compound with H-169%3B loss of activity. D->DD;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16845398,ECO:0000269|PubMed:17293595;Dbxref=PMID:16845398,PMID:17293595	
Q9NSU2	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_070901;Note=In AGS1 and SLE. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20131292;Dbxref=PMID:20131292	
Q9NSU2	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_032940;Note=In AGS1%3B autosomal dominant form%3B no effect on dsDNA exonuclease activity%3B abolishes ssDNA exonuclease activity. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17357087,ECO:0000269|PubMed:17846997,ECO:0000269|PubMed:23979357;Dbxref=dbSNP:rs78846775,PMID:17357087,PMID:17846997,PMID:23979357	
Q9NSU2	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_028321;Note=In AGS1%3B reduces activity by 75%25. V->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16845398,ECO:0000269|PubMed:17293595,ECO:0000269|PubMed:17846997;Dbxref=dbSNP:rs78408272,PMID:16845398,PMID:17293595,PMID:17846997	
Q9NSU2	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_037950;Note=In SLE%3B associated in cis with P-302. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17660818;Dbxref=dbSNP:rs113107733,PMID:17660818	
Q9NSU2	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_037951;Note=In SLE. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17660818;Dbxref=dbSNP:rs72556555,PMID:17660818	
Q9NSU2	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_037952;Note=In SLE%3B associated in cis with S-282. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17660818;Dbxref=dbSNP:rs112741962,PMID:17660818	
Q9NSU2	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_037953;Note=E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17660818;Dbxref=dbSNP:rs55999987,PMID:17660818	
Q9NSU2	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_037954;Note=In SLE%3B increases ubiquitination levels%3B no effect on exonuclease activity. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17660818,ECO:0000269|PubMed:23979357;Dbxref=dbSNP:rs148833270,PMID:17660818,PMID:23979357	
Q9NSU2	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_070902;Note=In AGS1%3B decreases ubiquitination levels%3B decreases colocalization with UBQLN1%3B no effect on exonuclease activity. T->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17846997,ECO:0000269|PubMed:23979357;Dbxref=dbSNP:rs76224909,PMID:17846997,PMID:23979357	
Q9NSU2	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_037955;Note=In SLE%3B decreases ubiquitination levels%3B decreases colocalization with UBQLN1%3B no effect on exonuclease activity. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17660818,ECO:0000269|PubMed:23979357;Dbxref=dbSNP:rs370504038,PMID:17660818,PMID:23979357	
Q9NSU2	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_037956;Note=In SLE. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17660818;Dbxref=dbSNP:rs780022923,PMID:17660818	
Q9NSU2	UniProtKB	Mutagenesis	30	30	.	.	.	Note=Reduces ubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Mutagenesis	66	66	.	.	.	Note=No effect on ubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Mutagenesis	75	75	.	.	.	Note=Reduces ubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Reduces ubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Reduces ubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Mutagenesis	242	242	.	.	.	Note=Reduces ubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Mutagenesis	271	271	.	.	.	Note=Reduces ubiquitination. Strongly reduces ubiquitination%3B when associated with R-277. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Mutagenesis	277	277	.	.	.	Note=Reduces ubiquitination. Strongly reduces ubiquitination%3B when associated with R-271. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23979357;Dbxref=PMID:23979357	
Q9NSU2	UniProtKB	Sequence conflict	265	265	.	.	.	Note=G->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
